We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go: Expired investment: Withheld
Active Needle Technology offers an award-winning "needle actuating device" which has high value medical and consumer applications. The company's patent-pending proprietary ultrasonic technology enhances visibility for medical needles in applications such as biopsy, in regional and joint anaesthesia and others. The company aims to commercialise its technology into a $4+ billion special purpose needle market. After identifying obvious commercial advantages in the tattoo market, Active Needle plans to use its ultrasonic needle technology to develop a low-pain tattooing system. Moreover, the company has won an Innovate UK grant to develop and test the tattoo device. With the proceeds, the company will complete CE marking for its initial biopsy device, for development of anaesthesia and tattooing products.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £194,100
ISO Spaces designs and manufactures bespoke modular buildings made from recycled shipping containers. ISO Spaces have previously converted shipping containers into bars, restaurants, retail spaces, offices and accomodation. To date they have worked with some well known brands such as; Jeep, EE and the BBC. 
days to go: Expired investment: £448,690
TC BioPharm is an immunotherapy company. It has used its patented technology to harness the power of a particular part of the immune system, Gamma Delta T-cells (GDT), to negate cancer cells in the human body. TC BioPharm has treated terminally ill patients with acute myeloid leukaemia in approved clinical trials garnering positive responses from multiple patients. The company has received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to run a COVID-19 clinical trial to address the global pandemic. TC BioPharm aims to use its current technology to provide a frozen product that can be manufactured cost-effectively and distributed globally. The company has already raised over £7 million in the last 15 months. It will use the investment to take its clinical trials forward in COVID-19 and cancer.

Pitch Rated

59%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,753,067
Stericile Ltd is a chemical R&D company that has scientifically created a disinfectant meant to combat the epidemic of Hospital Acquired Infections. The company has achieved the biggest technological advancement in the peracetic acid market, having spent over £400,000 to create a unique chemical solution for the healthcare market. Stericile Ltd has secured a UK national supplier that caters to 15,000+ healthcare customers such as dentist & doctor surgeries, care homes, and medical centres with less effective products.
days to go: Expired investment: £229,200
Orthogem is a UK based manufacturer of synthetic bone grafts. Synthetic bone grafts are substitutes for human bone grafts and are designed to replace bone that has been lost. Orthogem have recently started to produce their product in a putty form in order to keep up with the changes in the market. 
days to go: Expired investment: £722,784
Swiss-licensed medical cannabis producer, swisscann, targets the expansive €12 billion global medical cannabis market, with an EU distribution agreement already secured. Leveraging its THC-licensed production facility, the company aims to meet the rising demand for safe and effective medical cannabis products, boasting a cultivation license and a partnership with a publicly listed European pharmaceutical distributor. Strategically headquartered in Zurich, Switzerland, swisscann benefits from proximity to Germany, Europe's largest medical cannabis market projected to reach multibillion-Euro valuations by 2027. Anticipating availability in European pharmacies and an initial launch in the German market by Q1 2024, swisscann aims to establish its foothold in the European medical cannabis landscape.
days to go: Expired investment: £1,067,294
Please watch the video for more information
days to go: Expired investment: £360,250
A photography company helping 'amateur' photographers to license their images for businesses to use. Picfair has more than 35,000 photographers from 130+ countries signed up to the service, which allows them to sell their work at a price of their choice. Picfair have seen their client's images appear on global marketing campaigns and on the front page of international publications. Investment will enable multiple streams of income and develop further global network reach.
days to go: Expired investment: £419,830
Really Local Group (RLG) aims at creating vibrant high street community spaces that promote local culture, arts and area regeneration in the UK. The company has a pipeline of 6 sites across London and South East England. Each of the company's bespoke venues provides a mixture of a 3-4 screen cinema with community spaces, a vibrant live music and comedy programme, coffee shop, bar with a wide range of locally sourced offerings, and ‘Pop Up’ stalls for local traders. RLG has raised £1.25 million from third-party investors. The company will use 80% of the investment to develop its second site, the 'Biscuit Factory' in Reading, and 20% to progress design work on its pipeline sites in Bermondsey, Sidcup and Canning Town.
days to go: Expired investment: £250,410
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph